Cambrex Breaks Ground on $120 Million Expansion in Charles City, Iowa
Cambrex Breaks Ground on $120 Million Expansion in Charles City, Iowa
October 30, 2026
Medical Device News and MedTech Industry News
Latest News
Cambrex Breaks Ground on $120 Million Expansion in Charles City, Iowa
BioArctic’s Nomination Committee appointed
Arthrex Ankle Innovation Named “Coolest Thing Made in Florida”
Lubrizol Launches Tecothane™ Soft AR-65A TPU for Interventional Medical Devices
Cairn Surgical Announces Publication of Pivotal Randomized Trial Results Demonstrating Lower Positive Margin Rates Using Breast Cancer Locator System In Breast-Conserving Surgery
Dave Larcenaire Named General Manager of Allient Denver
Medical Device News
Stay informed with the latest medical device news and developments shaping the global MedTech industry. Medical Device News Magazine delivers coverage of innovative medical technologies, FDA approvals and clearances, clinical trials, product launches, and emerging technologies transforming patient care.
Explore news and insights from medical device manufacturers, healthcare technology companies, researchers, and industry leaders. From advances in medical imaging and artificial intelligence to regulatory developments, funding, and acquisitions, our coverage helps healthcare professionals, industry executives, and investors stay informed about the evolving medical device landscape.
Medical Device News
Arthrex Ankle Innovation Named “Coolest Thing Made in Florida”
The Syndesmosis TightRope PRO implant builds on more than 20 years of TightRope technology, with earlier iterations being used to treat hundreds of thousands of patients, including former NFL tight end Kyle Rudolph and current NFL quarterback Riley Leonard.
October 29, 2026
Robotic Surgery Enables Effective and Safe Repair of Hard-to-Reach Abdominal Hernias
The study was led by Dr. Michael Freund of the Hebrew University of Jerusalem (HU) Faculty of Medicine and Shaare Zedek Medical Center in collaboration with Prof. David Hazzan of Raphael Hospital, Sheba Medical Center and Tel Aviv University
October 14, 2026
Shoreline Medical Administration, CHUM Health and Cellution Biologics Launch Elite Graft Program for Advanced Wound Care
New collaborative program brings together an industry leading biologic graft, wound care specific revenue cycle management and the only clawback protection program in one coordinated solution
October 13, 2026
Biotechnology News
Lubrizol Launches Tecothane™ Soft AR-65A TPU for Interventional Medical Devices
Very soft, 100% TPU combines 65A performance with chemical resistance, thin-wall processability, and manufacturing versatility
October 28, 2026
Lunit and Discovery Life Sciences Collaborate to Expand AI-Powered Tissue Analysis for Biopharma Research
Collaboration expands access to Lunit’s AI-powered pathology platform by combining it with Discovery Life Sciences’ global biospecimen and specialty laboratory capabilities, enabling standardized tissue insights for biomarker research and drug development
October 12, 2026
CancerIQ Deepens EHR Integrations to Identify and Guide More Patients Through Cancer Screening, Testing and Surveillance
A redesigned patient experience drives engagement from prevention through survivorship, while chart-aware risk intelligence surfaces guideline-based recommendations in EHR workflows
September 24, 2026
Biotechnology News
Daewoong Pharmaceutical Presents Baseline Characteristics of 104 Patients in Global Phase 2 Trial for IPF Drug Candidate ‘Bersiporocin’ at ERS 2026
104 IPF patients enrolled in US and South Korea as global Phase 2 trial progresses toward completion
September 24, 2026
Industry Bylines
The New Dealbreaker in Medical Device Procurement? Cybersecurity | By Phil Englert is the VP of Medical Device Security for Health-ISAC
Any connected device can be exploited. Recognizing that truth, we must try to ensure that when a vulnerability inevitably emerges, there’s a plan, and everyone involved knows what to do next
October 2, 2026
Beyond the Robot: The Next Frontier of Innovation in Robotic Surgery | By Melissa Kelly BBA, BSN, RN, CNOR Global Clinical Manager, Gentherm Medical
The future of robotic surgery won’t be defined solely by how advanced the robot becomes. It will also be defined by how well the technologies around it help clinicians deliver safer, more consistent and more patient-centered care
September 23, 2026
How Clinical Education Shapes Medical Device Adoption
A practical framework for helping clinicians move from product to practice | By Steve Deverall, CEO and co-founder of InfuseMed
September 21, 2026
The MedTech Advantage in Right-Sized Technology | By Mike King, Senior Director, Product & Strategy, Quality, Regulatory, Safety & Detect, IQVIA
Why Growing Device Companies Should Stop Copying Big Pharma’s Technology Playbook
September 16, 2026
MedTech Companies, Funding and Acquisitions
Carrot Announces Agreement to Acquire GreenMan InSightVR, Expanding Eye Care’s Leading VR Diagnostics Platform Into Vision Simulation
The company that invented VR visual testing, now trusted in 2,500+ clinics for more than 6 million eye exams, will add immersive, interactive IOL simulation—bringing testing, diagnostics and simulation onto one platform
October 9, 2026
Zenflow Secures $52M Series D Financing and Announces Exclusive U.S. Distribution Partnership with Cook Medical
Series D proceeds to support commercialization of the Zenflow Spring® System for Men with Enlarged Prostate
October 5, 2026
108 BioCapital Leads SedMed, Inc. Financing with $4 Million Investment
The financing will support SedMed’s next phase of commercial growth and expand access to its non-electric toilet lift, which is designed to help older adults and individuals with mobility limitations sit and stand more safely and independently while reducing strain on caregivers
October 1, 2026
Labsphere Acquires Photon Gear, Adding Ultra-High-Precision Optical Design and Assembly
Combination pairs Labsphere’s light generation, control, and measurement platform with Photon Gear’s custom lens design, assembly, and interferometric test
October 1, 2026
FDA Approvals and Medical Device Innovations
Penumbra’s CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
BOLT-DVT, a recent prospective, multicenter Investigational Device Exemption (IDE) trial, demonstrated first-line use of computer assisted vacuum thrombectomy (CAVT) for DVT is safe and effective
October 20, 2026
FDA clears Mass General Brigham–developed antibiotic delivery system for knee replacement infections
Temporary knee spacer delivers antibiotics directly to an infected joint while providing load-bearing structural support during treatment
October 7, 2026
Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition
For the first time, U.S. CardioMEMS patients will be able to view pulmonary artery pressure (PAP) readings and receive personalized medication updates through the CardioGuide HF App. Rising PAP can signal worsening heart failure weeks before patients experience symptoms.
New capabilities help patients take a more active role in their care and stay connected to their care teams between doctor visits
October 5, 2026
BTL Expands EXOMIND® Platform with New FDA Clearances
The new clearances expand its reach to additional brain targets and conditions, including obsessive-compulsive disorder (OCD), MDD comorbid anxiety, and extend care to adolescent patients
October 1, 2026
Medical Device Clinical Trials and Research
Cairn Surgical Announces Publication of Pivotal Randomized Trial Results Demonstrating Lower Positive Margin Rates Using Breast Cancer Locator System In Breast-Conserving Surgery
The BCL Trial is an international, prospective, multicenter, randomized controlled trial conducted at 23 sites by 44 surgeons in the U.S., Canada, U.K., and Austria comparing the effectiveness and safety of the BCL System versus conventional WL in 418 patients with non-palpable, MRI-visualized invasive breast cancer or DCIS
October 28, 2026
Brainomix AI Imaging Analysis of Phase 3 CHARM Trial Identifies Promising Treatment Signals in Severe Stroke Patients
AI-powered analysis of Phase 3 CHARM trial suggests that Brainomix non-contrast CT (NCCT) technology may help identify severe stroke patients more likely to benefit from CIRARA, supporting more precise patient selection and the design of future stroke trials.
October 28, 2026
NEW STUDY – Published data on Jupiter Endovascular’s thrombectomy system shows normalization for fully 50% of patients, with all endpoints met
Peer-reviewed Data Published in EuroIntervention Also Demonstrated Vertex System Achieved Rapid Afterload Relief – or Reduction in Heart Strain – and Symptom Improvement
October 19, 2026
Vagus Nerve Stimulation Trial Is Available to Patients With Lupus
The bioelectronic medicine trial will study how non-invasive stimulation might treat pain and fatigue in patients with lupus
October 12, 2026
BioArctic’s Nomination Committee appointed
The Nomination Committee has been appointed in accordance with the principles adopted by the Annual General Meeting and consists of representatives of the three largest shareholders by voting rights as of September 30, 2026, as well as the Chair of the Board (convener)
October 30, 2026
Dave Larcenaire Named General Manager of Allient Denver
Dave brings more than 30 years of experience in precision motion, automation and advanced technology markets.
October 28, 2026
Catherine Jennings Named President of Beckman Coulter Diagnostics
Jennings brings more than 20 years of healthcare industry leadership experience and a proven track record of driving growth, innovation and transformation across global healthcare organizations
October 14, 2026
Riccardo Fava Appointed New Group VP Investor Relations, Sustainability & Media Relations at Medacta
Riccardo Fava brings more than 20 years of experience across the medtech and financial sectors.
October 5, 2026
Professor Bill Sessa Appointed Chair of Isomab’s Scientific Advisory Board
Former Chief Scientific Officer of Internal Medicine at Pfizer: Leading vascular biologists from Yale, Harvard, Uppsala and the University of Eastern Finland join Sessa to advise on the development of ISM-001, Isomab’s first-in-class anti-VEGF-A165b antibody for chronic angina
September 29, 2026
For industry partners